These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30323818)

  • 1. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
    Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
    Front Immunol; 2018; 9():2247. PubMed ID: 30323818
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood
    Vickers MA; Darboe F; Muefong CN; Mbayo G; Barry A; Gindeh A; Njie S; Riley AJ; Sarr B; Sambou B; Dockrell HM; Charalambous S; Rachow A; Owolabi O; Jayasooriya S; Sutherland JS
    Front Immunol; 2020; 11():572620. PubMed ID: 33679684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment.
    Díaz-Fernández S; Villar-Hernández R; Stojanovic Z; Fernández M; Galvão MLS; Tolosa G; Sánchez-Montalva A; Abad J; Jiménez-Fuentes MÁ; Safont G; Romero I; Sabrià J; Prat C; Domínguez J; Latorre I
    Front Microbiol; 2022; 13():885312. PubMed ID: 35935194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control diagnostic accuracy study of a non-sputum CD38-based TAM-TB test from a single milliliter of blood.
    Hiza H; Hella J; Arbués A; Magani B; Sasamalo M; Gagneux S; Reither K; Portevin D
    Sci Rep; 2021 Jun; 11(1):13190. PubMed ID: 34162973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27
    Fang Y; Wang N; Tang L; Yang XJ; Tang Y; Li L; Wu WF; Su B; Sha W
    BMC Infect Dis; 2022 Dec; 22(1):899. PubMed ID: 36457066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD38+CD27-TNF-α + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
    Acharya MP; Pradeep SP; Murthy VS; Chikkannaiah P; Kambar V; Narayanashetty S; Burugina Nagaraja S; Gangadhar N; Yoganand R; Satchidanandam V
    Clin Infect Dis; 2021 Sep; 73(5):793-801. PubMed ID: 34492697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans.
    Nikitina IY; Kondratuk NA; Kosmiadi GA; Amansahedov RB; Vasilyeva IA; Ganusov VV; Lyadova IV
    PLoS One; 2012; 7(8):e43733. PubMed ID: 22937086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion.
    Riou C; Gray CM; Lugongolo M; Gwala T; Kiravu A; Deniso P; Stewart-Isherwood L; Omar SV; Grobusch MP; Coetzee G; Conradie F; Ismail N; Kaplan G; Fallows D
    PLoS One; 2014; 9(7):e102178. PubMed ID: 25048802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.
    Rodrigues DS; Medeiros EA; Weckx LY; Bonnez W; Salomão R; Kallas EG
    Clin Exp Immunol; 2002 Apr; 128(1):149-54. PubMed ID: 11982602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection.
    Silveira-Mattos PS; Barreto-Duarte B; Vasconcelos B; Fukutani KF; Vinhaes CL; Oliveira-De-Souza D; Ibegbu CC; Figueiredo MC; Sterling TR; Rengarajan J; Andrade BB
    Clin Infect Dis; 2020 Nov; 71(8):1905-1911. PubMed ID: 31665254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo.
    Schuetz A; Haule A; Reither K; Ngwenyama N; Rachow A; Meyerhans A; Maboko L; Koup RA; Hoelscher M; Geldmacher C
    PLoS One; 2011; 6(11):e27284. PubMed ID: 22087280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease extent and anti-tubercular treatment response correlates with
    Riou C; Du Bruyn E; Ruzive S; Goliath RT; Lindestam Arlehamn CS; Sette A; Sher A; Barber DL; Wilkinson RJ
    Clin Transl Immunology; 2020; 9(9):e1176. PubMed ID: 33005414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of
    Sitoe N; Ahmed MIM; Enosse M; Bakuli A; Chissumba RM; Held K; Hoelscher M; Nhassengo P; Khosa C; Rachow A; Geldmacher C; On Behalf Of Tb Sequel Consortium
    Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection.
    Morais-Papini TF; Coelho-Dos-Reis JGA; Wendling APB; do Vale Antonelli LR; Wowk PF; Bonato VLD; Augusto VM; Elói-Santos S; Martins-Filho OA; Carneiro CM; Teixeira-Carvalho A
    Immunobiology; 2017 Nov; 222(11):1014-1024. PubMed ID: 28619539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.